首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   49770篇
  免费   3634篇
  国内免费   1792篇
  2023年   640篇
  2022年   722篇
  2021年   1537篇
  2020年   1747篇
  2019年   2225篇
  2018年   1912篇
  2017年   1308篇
  2016年   1289篇
  2015年   1679篇
  2014年   2932篇
  2013年   3246篇
  2012年   1898篇
  2011年   2557篇
  2010年   1824篇
  2009年   2311篇
  2008年   2474篇
  2007年   2462篇
  2006年   2308篇
  2005年   2037篇
  2004年   1713篇
  2003年   1457篇
  2002年   1245篇
  2001年   897篇
  2000年   868篇
  1999年   740篇
  1998年   726篇
  1997年   694篇
  1996年   714篇
  1995年   733篇
  1994年   727篇
  1993年   657篇
  1992年   673篇
  1991年   589篇
  1990年   547篇
  1989年   480篇
  1988年   420篇
  1987年   413篇
  1986年   330篇
  1985年   421篇
  1984年   454篇
  1983年   295篇
  1982年   424篇
  1981年   326篇
  1980年   276篇
  1979年   245篇
  1978年   173篇
  1977年   156篇
  1976年   149篇
  1973年   116篇
  1972年   81篇
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
21.
22.
Summary The present study was done to elucidate the biological significance of the Weibel-Palade body of human umbilical vein endothelial cells. Quantitative determinations of these endothelial-specific granules throughout pregnancy revealed that their numbers and size per cell profile were maintained at low levels from 12 to 19 weeks of gestation; then both rapidly increased from 33 weeks to full term. This increase coincided with the development of the rough endoplasmic reticulum and an increase in the number of endothelial cell pinocytotic vesicles. Light-microscopic peroxidase anti-peroxidase and electron-microscopic protein A-gold techniques provided evidence that factor VIII-related antigen was localized in the Weibel-Palade bodies. Furthermore, in vitro treatment of incubated umbilical vein tissue with compound 48/80, a histamine releaser, induced degranulation of Weibel-Palade bodies from the endothelium. The present study indicates that Weibel-Palade bodies are storage sites of both histamine and factor VIII-related antigen and have an important role in the obliteration of this vessel.  相似文献   
23.
MiR-204 is expressed in vascular smooth muscle cells (VSMC). However, its role in VSMC contraction is not known. We determined if miR-204 controls VSMC contractility and blood pressure through regulation of sarcoplasmic reticulum (SR) calcium (Ca2+) release. Systolic blood pressure (SBP) and vasoreactivity to VSMC contractile agonists (phenylephrine (PE), thromboxane analogue (U46619), endothelin-1 (ET-1), angiotensin-II (Ang II) and norepinephrine (NE) were compared in aortas and mesenteric resistance arteries (MRA) from miR-204−/− mice and wildtype mice (WT). There was no difference in basal systolic blood pressure (SBP) between the two genotypes; however, hypertensive response to Ang II was significantly greater in miR-204−/− mice compared to WT mice. Aortas and MRA of miR-204−/− mice had heightened contractility to all VSMC agonists. In silico algorithms predicted the type 1 Inositol 1, 4, 5-trisphosphate receptor (IP3R1) as a target of miR-204. Aortas and MRA of miR-204−/− mice had higher expression of IP3R1 compared to WT mice. Difference in agonist-induced vasoconstriction between miR-204−/− and WT mice was abolished with pharmacologic inhibition of IP3R1. Furthermore, Ang II-induced aortic IP3R1 was greater in miR-204−/− mice compared to WT mice. In addition, difference in aortic vasoconstriction to VSMC agonists between miR-204−/− and WT mice persisted after Ang II infusion. Inhibition of miR-204 in VSMC in vitro increased IP3R1, and boosted SR Ca2+ release in response to PE, while overexpression of miR-204 downregulated IP3R1. Finally, a sequence-specific nucleotide blocker that targets the miR-204-IP3R1 interaction rescued miR-204-induced downregulation of IP3R1. We conclude that miR-204 controls VSMC contractility and blood pressure through IP3R1-dependent regulation of SR calcium release.  相似文献   
24.
Genetically modified Saccharomyces cerevisiae strain (YPB-G) which secretes a bifunctional fusion protein that contains both Bacillus subtilis -amylase and Aspergillus awamori glucoamylase activities was used for the direct conversion of starch into ethanol. Starch was either supplied initially to different nutrient media or added instantaneously to the reactor at various discrete time instants (pulse feeding). Stoichiometric modeling was used to investigate the effects of initial substrate concentration and growth rate of the recombinant yeast culture on ethanol production. Reaction stoichiometries describing both the anabolism and catabolism of the microorganism were used as an input to flux balance analysis (FBA), the preferred metabolic modeling approach since the constructed stoichiometric network was underdetermined. Experiments for batch and fed-batch systems at different substrate concentrations were analyzed theoretically in terms of flux distributions using ethanol production rate as the maximization criteria. Calculated ethanol rates were in agreement with experimental measurements, suggesting that this recombinant microorganism is sufficiently evolved to optimize its ethanol production. The function of the main pathways of yeast metabolism (PPP, EMP, TCA) are discussed together with the node analyses of glucose-6-P and pyruvate branch points. Theoretical node analysis revealed that if the split ratio in G6P branch point is changed by genetic manipulations, the ethanol yield would be affected considerably.  相似文献   
25.
《Developmental cell》2022,57(5):610-623.e8
  1. Download : Download high-res image (131KB)
  2. Download : Download full-size image
  相似文献   
26.
《Cell reports》2020,30(7):2065-2074.e4
  1. Download : Download high-res image (155KB)
  2. Download : Download full-size image
  相似文献   
27.
《Cell reports》2020,30(7):2055-2064.e5
  1. Download : Download high-res image (99KB)
  2. Download : Download full-size image
  相似文献   
28.
《Cell reports》2020,30(3):739-754.e4
  1. Download : Download high-res image (99KB)
  2. Download : Download full-size image
  相似文献   
29.
Neurotoxic Esterase in Human Nervous Tissue   总被引:1,自引:1,他引:0  
  相似文献   
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号